FDA reverses course, agrees to review Moderna’s flu vaccine
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
The FDA has reversed its previous stance and will review Moderna's flu vaccine. This decision marks a change in the FDA's approach to the vaccine. The FDA will now conduct a review of the vaccine.